Physician profile
Lawrence Chen
NPI 1265927115
$25,125.19
in general payments reported to CMS, 2019-2025
17 companies · $2,398 in 2025
The $2,398 reported for 2025 was more than what 92% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $5,818 · 2023: $8,614 · 2024: $8,295 · 2025: $2,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,886 · Consulting Fee: $6,150 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Travel and Lodging: $2,271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,885.97 |
| Consulting Fee | $6,150.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Travel and Lodging | $2,271.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $15,212.26 | 2022-2025 | |
| Evolution Surgical, INC | $1,913.30 | 2022-2025 | |
| Orthofix Medical, INC. | $1,409.24 | 2022 | |
| Paragon 28, INC. | $1,210.11 | 2022 | |
| Arthrex, INC. | $1,202.10 | 2023 | |
| Rock Medical Orthopedics, INC. | $1,200.00 | 2022 | |
| Smith+Nephew, INC. | $873.35 | 2022-2025 | Collagenase Santyl, Stravix, Stravix Pl |
| Organogenesis INC. | $562.96 | 2023-2025 | Puraply, Puraply Wound Matrix |
| Stryker Corporation | $475.86 | 2023-2025 | Prostep, Ortholoc 2 Lapifuse, Prostep Mica |
| Boston Scientific Corporation | $294.28 | 2024-2025 | Watchman Flx, General - Pain Management |
| Treace Medical Concepts, INC. | $189.59 | 2024 | |
| Nevro Corp. | $166.04 | 2023 | Senza |
| Mimedx Group, INC. | $138.00 | 2025 | |
| Hydrofera LLC | $123.49 | 2023 | Hydrofera Blue |
| Integra Lifesciences Corporation | $74.11 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $51.64 | 2025 | Krystexxa |
| Vertex Pharmaceuticals Incorporated | $28.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.